HYPR — Hyperfine Inc
NASDAQ · Healthcare · Medical Devices
$0.81
+$0.00 (+0.00%)
Hyperfine Inc (HYPR) is a medical devices company listed on NASDAQ. It is led by Maria Degois-Sainz, based in 351 New Whitfield Street, Guilford, CT, United States, 06437, with about 102 employees. Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
Latest reported HYPR revenue for 2025-09-30 was $3.4M. Net income was -$29.7M. Revenue was up 27.5% from 2025-06-30 to 2025-09-30. HYPR currently screens at market cap $141.5M.
Use this HYPR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HYPR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HYPR SEC filings page. Lician reads the product cache first so this HTML stays unique to Hyperfine Inc even when a live quote feed is slow.
About Hyperfine Inc
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
HYPR Key Statistics
Market Cap
$141.46M
Volume
394,115
Previous Close
$0.86
Day Range
$0.85 – $0.88
P/B Ratio
4.02
EPS
-$0.56
Revenue
$12.89M
Net Income
-$40.72M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+16.8%
Profit Margin
-315.9%
Employees
102
HYPR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $12.89M | $11.03M | $6.81M | $1.50M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$40.72M | -$44.24M | -$73.16M | -$64.85M |
| EPS (Diluted) | -$0.56 | -$0.62 | -$1.04 | -$17.57 |
Total Assets
$58.90M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$37.65M
Operating Cash Flow
-$38.77M
Free Cash Flow
$0.00
Hyperfine Inc Company Information
- CEO, President & Director
- Maria Degois-Sainz
- Headquarters
- 351 New Whitfield Street, Guilford, CT, United States, 06437
- Website
- www.hyperfinemri.com
- Phone
- 866 796 6767
- IPO / Founded
- 2021-01-27
- Sector
- Healthcare
- Industry
- Medical Devices